English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51541935    Online Users :  906
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"jia horng kao"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 306-355 of 1180  (24 Page(s) Totally)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-09-04T06:12:23Z Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:22Z Outcomes of HCV treatment: Who does well and who does not? Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:22Z Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection Hsu C.-S.; Liu C.-H.; Liu C.-J.; Hsu S.-J.; Chen C.-L.; Hwang J.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:22Z Role of Viral Factors in Modifying Weight-Related Effects on Disease Progression of Chronic Hepatitis C Patients Hsu C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:22Z Alanine aminotransferase, metabolic syndrome, and cardiovascular disease: A missing link Wang C.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:21Z Optimal management of hepatocellular carcinoma: Challenges and opportunities Lin C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:21Z Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: A ten-year observation Huang Z.-S.; Huang T.-S.; Wu T.-H.; Chen M.-F.; Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:21Z The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C Liu C.-H.; Liang C.-C.; Liu C.-J.; Hsu S.-J.; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen J.-H.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:20Z Intrathecal delivery of a mutant μ-opioid receptor activated by naloxone as a possible antinociceptive paradigm JIA-HORNG KAO; Chen S.L.; Ma H.I.; Law P.Y.; Tao P.L.; Loh H.H.
臺大學術典藏 2021-09-04T06:12:20Z Clinical implications of hepatitis B virus variants Lin C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:20Z Hepatitis C infection and metabolic syndrome. Hsu C.S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:19Z Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan Huang Y.-W.; Liao Y.-T.; Chen W.; Chen C.-L.; Hu J.-T.; Liu C.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Yang S.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:19Z Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma. Epidemiologic and molecular biological aspects JIA-HORNG KAO; Chen P.-J.; Chen D.-S.
臺大學術典藏 2021-09-04T06:12:19Z Recent advances in clinical application of gut hormones Tseng P.-H.; Wu M.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:18Z Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection Hsu C.-S.; Wang C.-C.; Wang P.-C.; Lin H.H.; Tseng T.-C.; Chen C.-H.; Su W.-C.; Liu C.-J.; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:18Z Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B Su T.-H.; Hsu C.-S.; Chen C.-L.; Liu C.-H.; Huang Y.-W.; Tseng T.-C.; Liu C.-J.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:17Z Metabolic syndrome on top of chronic hepatitis B: The more, the worse? Chang L.-C.; Chung C.-S.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:17Z Carvedilol versus variceal band ligation for prevention of the first variceal bleed Wang C.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:17Z Metformin improves sustained virologic response in difficult-to-cure hepatitis c: More questions than answers Wang C.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:17Z From liver markers to life expectancy Wang C.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:16Z Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy Lui Y.Y.-N.; Tsoi K.K.-F.; Wong V.W.-S.; JIA-HORNG KAO; Hou J.-L.; Teo E.-K.; Mohamed R.; Piratvisuth T.; Han K.-H.; Mihm U.; Wong G.L.-H.; Chan H.L.-Y.
臺大學術典藏 2021-09-04T06:12:16Z Letter to the editor Wang C.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:16Z Use of statins and gallstone risk [1] Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:15Z Rifaximin treatment in hepatic encephalopathy [1] Wang C.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:15Z Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B Huang Y.-W.; Chayama K.; Tsuge M.; Takahashi S.; Hatakeyama T.; Abe H.; Hu J.-T.; Liu C.-J.; Lai M.-Y.; Chen D.-S.; Yang S.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:15Z A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection Tong M.J.; Hsu L.; Hsien C.; JIA-HORNG KAO; Durazo F.A.; Saab S.; Blatt L.M.
臺大學術典藏 2021-09-04T06:12:14Z Treatment of chronic hepatitis B in Asia-Pacific countries: Is the Asia-Pacific consensus statement being followed? Sung J.J.Y.; Amarapurkar D.; Chan H.L.Y.; Cheng J.; JIA-HORNG KAO; Han K.-H.; Piratvisuth T.
臺大學術典藏 2021-09-04T06:12:14Z Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C Liu C.-H.; Liang C.-C.; Liu C.-J.; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:14Z HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; Chen C.-L.; JIA-HORNG KAO; Lai M.-Y.; Liu C.-H.; Su T.-H.; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Chen P.-J.; Liu C.-J.; Chen D.-S.
臺大學術典藏 2021-09-04T06:12:13Z Treatment of hepatitis C virus infection in patients with end-stage renal disease Liu C.-H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:13Z Implications of hepatitis B virus genomic variations on treatment outcomes Tseng T.-C.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:13Z The clinical implications of hepatitis B virus genotype: Recent advances Lin C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:13Z Hepatitis B e antigen seroconversion: A critical event in chronic hepatitis B virus Infection Liaw Y.-F.; Lau G.K.K.; JIA-HORNG KAO; Gane E.
臺大學術典藏 2021-09-04T06:12:12Z Entecavir: A review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease Keating G.M.; Buti M.; Gadano A.; JIA-HORNG KAO; Lee C.-M.; Peng C.-Y.; Schiff E.R.; Tanwandee T.
臺大學術典藏 2021-09-04T06:12:12Z Interleukin-28B genetic variations and response to interferon-based therapy: Asian perspectives Liu C.-H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:12Z Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses Yeh M.-L.; Hung C.-H.; Huang J.-F.; Liu C.-J.; Lee C.-M.; Dai C.-Y.; Wang J.-H.; Lin Z.-Y.; Lu S.-N.; Hu T.-H.; Yu M.-L.; JIA-HORNG KAO; Chuang W.-L.; Chen P.-J.; Chen D.-S.
臺大學術典藏 2021-09-04T06:12:11Z Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan Mah Y.-H.; Hsu C.-S.; Liu C.-H.; Liu C.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:11Z Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy Tseng T.-C.; Yu M.-L.; Liu C.-J.; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; Liu C.-H.; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:10Z Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients Liu C.-H.; Liang C.-C.; Huang K.-W.; Liu C.-J.; Chen S.-I.; Lin J.-W.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen J.-H.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:10Z HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infection Hsu S.-J.; Hsu C.-S.; Liu C.-H.; Liu C.-J.; Chen C.-L.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:10Z Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters Tseng T.; Liu C.; Su T.; Wang C.; Chen C.; Chen P.; Chen D.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:09Z Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization Wen W.-H.; Chen H.-L.; Ni Y.-H.; Hsu H.-Y.; JIA-HORNG KAO; Hu F.-C.; Chang M.-H.
臺大學術典藏 2021-09-04T06:12:09Z Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: Genotype B vs C Liu C.-J.; Cheng H.-R.; Chen C.-L.; Chen T.-C.; Tseng T.-C.; Wang Z.-L.; Chen P.-J.; Liu C.-H.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:09Z The clinical significance of occult hepatitis B transfusion in Taiwan - a look-back study Su T.-H.; Chen P.-J.; Chen T.-C.; Cheng H.-R.; Li L.; Lin K.-S.; JIA-HORNG KAO; Chen D.-S.; Liu C.-J.
臺大學術典藏 2021-09-04T06:12:08Z Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load Wang J.-Y.; Liu C.-H.; Hu F.-C.; Chang H.-C.; Liu J.-L.; Chen J.-M.; Yu C.-J.; Lee L.-N.; JIA-HORNG KAO; Yang P.-C.
臺大學術典藏 2021-09-04T06:12:08Z Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy Hsu C.-S.; Hsu S.-J.; Chen H.-C.; Tseng T.-C.; Liu C.-H.; Niu W.-F.; Jeng J.; Liu C.-J.; Lai M.-Y.; Chen P.-J.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏 2021-09-04T06:12:08Z Il-28b predicts response to chronic hepatitis C therapy -fine-mapping and replication study in Asian populations Ochi H.; Maekawa T.; Abe H.; Hayashida Y.; Nakano R.; Imamura M.; Hiraga N.; Kawakami Y.; Aimitsu S.; JIA-HORNG KAO; Tsunoda M.K.; Tsunoda T.; Kumada H.; Nakamura Y.; Hayes N.C.; Chayama K.
臺大學術典藏 2021-09-04T06:12:07Z Reply to Guedj et al.: Early transient increase of hepatitis C virus viral load in genotype 1 and 2 infections, and the use of mathematical modeling Hsu C.-S.; Chen H.-C.; Jeng J.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏 2021-09-04T06:12:07Z Boceprevir for chronic HCV genotype 1 infection [2] Hsu, C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:07Z Functional impairment of dendritic cells in patients infected with hepatitis C virus genotype 1 who failed peginterferon plus ribavirin therapy Liang C.-C.; Liu C.-H.; Lin Y.-L.; Liu C.-J.; Chiang B.-L.; JIA-HORNG KAO

Showing items 306-355 of 1180  (24 Page(s) Totally)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
View [10|25|50] records per page